Home » Sales of Trimeris’ Fuzeon Fall 39 Percent in 4Q
Sales of Trimeris’ Fuzeon Fall 39 Percent in 4Q
Global sales of Trimeris’ AIDS drug, Fuzeon, fell by 39 percent in the fourth quarter, continuing the treatment’s downward trend.
Triangle Business Journal
Triangle Business Journal
Upcoming Events
-
07May
-
14May
-
30May